| Budget Amount *help |
¥23,660,000 (Direct Cost: ¥18,200,000、Indirect Cost: ¥5,460,000)
Fiscal Year 2016: ¥6,890,000 (Direct Cost: ¥5,300,000、Indirect Cost: ¥1,590,000)
Fiscal Year 2015: ¥7,540,000 (Direct Cost: ¥5,800,000、Indirect Cost: ¥1,740,000)
Fiscal Year 2014: ¥9,230,000 (Direct Cost: ¥7,100,000、Indirect Cost: ¥2,130,000)
|
|---|
| Outline of Final Research Achievements |
A platform for biomarker discovery and diagnosis with multiple mass spectrometry (MS)-driven metabolite analytical platform were developed. This platform includes, 1. high-throughput metabolite analysis system, 2. spatiotemporally-resolved metabolite analysis system, and 3. standard-independent identification method of elemental composition for metabolite annotation. By accelerating interdisciplinary technical fusion in diverse biomedical redox-related research fields, substantial development of drug discovery tool, diagnostic methodology and instrument is in progress, and thus which lead to the establishment of new discipline of pathological metabolomics.
|
